A carregar...

Downregulation of CXXC Finger Protein 4 Leads to a Tamoxifen-resistant Phenotype in Breast Cancer Cells Through Activation of the Wnt/β-catenin Pathway

Tamoxifen is a successful endocrine therapy drug for estrogen receptor–positive (ER+) breast cancer. However, resistance to tamoxifen compromises the efficacy of endocrine treatment. In the present study, we identified potential tamoxifen resistance–related gene markers and investigated their mechan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yijie Fu, Zhu Wang, Chuanxu Luo, Yu Wang, Yanping Wang, Xiaorong Zhong, Hong Zheng
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020-02-01
Colecção:Translational Oncology
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S1936523319304401
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!